User profiles for Carlos R Oliveira
Carlos R. Oliveira, MD, PhDAssistant Professor, Clinical Scholar, Yale University School of Medicine Verified email at yale.edu Cited by 1162 |
Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine–associated myocarditis
Rare immune-mediated cardiac tissue inflammation can occur after vaccination, including
after SARS-CoV-2 mRNA vaccines. However, the underlying immune cellular and molecular …
after SARS-CoV-2 mRNA vaccines. However, the underlying immune cellular and molecular …
Severe acute respiratory syndrome coronavirus 2 clinical syndromes and predictors of disease severity in hospitalized children and youth
…, CR Oliveira, S Guerguis, R Eisenberg… - The Journal of …, 2021 - Elsevier
Objective To characterize the demographic and clinical features of pediatric severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) syndromes and identify admission …
respiratory syndrome coronavirus 2 (SARS-CoV-2) syndromes and identify admission …
Multicenter interim guidance on use of antivirals for children with coronavirus disease 2019/severe acute respiratory syndrome coronavirus 2
…, NO Dillman, KJ Downes, CR Oliveira… - Journal of the …, 2021 - academic.oup.com
Background Although coronavirus disease 2019 (COVID-19) is a mild infection in most
children, a small proportion develop severe or critical illness. Data describing agents with …
children, a small proportion develop severe or critical illness. Data describing agents with …
Initial guidance on use of monoclonal antibody therapy for treatment of coronavirus disease 2019 in children and adolescents
…, VL Soma, SP Grapentine, CR Oliveira… - Journal of the …, 2021 - academic.oup.com
Background In November 2020, the US Food and Drug Administration (FDA) provided
Emergency Use Authorizations (EUA) for 2 novel virus-neutralizing monoclonal antibody therapies…
Emergency Use Authorizations (EUA) for 2 novel virus-neutralizing monoclonal antibody therapies…
Chiral cyclopalladated complexes derived from N, N-dimethyl-1-phenethylamine with bridging bis (diphenylphosphine) ferrocene ligand as inhibitors of the cathepsin …
C Bincoletto, ILS Tersariol, CR Oliveira… - Bioorganic & medicinal …, 2005 - Elsevier
Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine and the
coordinating ligand 1,1′-bis(diphenylphosphine)ferrocene were synthesized and studied as …
coordinating ligand 1,1′-bis(diphenylphosphine)ferrocene were synthesized and studied as …
Updated guidance on use and prioritization of monoclonal antibody therapy for treatment of COVID-19 in adolescents
…, PK Sue, RM Olivero, CR Oliveira… - Journal of the …, 2022 - academic.oup.com
… Carlos R Oliveira , Carlos R Oliveira … Joshua Wolf, Mark J Abzug, Brenda I Anosike,
Surabhi B Vora, Alpana Waghmare, Paul K Sue, Rosemary M Olivero, Carlos R Oliveira, Scott H …
Surabhi B Vora, Alpana Waghmare, Paul K Sue, Rosemary M Olivero, Carlos R Oliveira, Scott H …
[HTML][HTML] Improvement of Long COVID symptoms over one year
Importance Early and accurate diagnosis and treatment of Long COVID, clinically known as
post-acute sequelae of COVID-19 (PASC), may mitigate progression to chronic diseases …
post-acute sequelae of COVID-19 (PASC), may mitigate progression to chronic diseases …
Brain magnetic resonance imaging of infants with bacterial meningitis
CR Oliveira, MC Morriss, JG Mistrot, JB Cantey… - The Journal of …, 2014 - Elsevier
Objectives To describe the results of brain magnetic resonance imaging (MRI) of infants with
bacterial meningitis and how the findings affected clinical management. Study design This …
bacterial meningitis and how the findings affected clinical management. Study design This …
Update on persistent symptoms associated with Lyme disease
CR Oliveira, ED Shapiro - Current opinion in pediatrics, 2015 - journals.lww.com
Patients with persistent symptoms possibly associated with Lyme disease often provide a
challenge for clinicians. Recent studies have provided additional evidence that viable B. …
challenge for clinicians. Recent studies have provided additional evidence that viable B. …
[HTML][HTML] A novel ruthenium complex with xanthoxylin induces S-phase arrest and causes ERK1/2-mediated apoptosis in HepG2 cells through a p53-independent …
…, ER Dos Santos, RMM Oliveira, RM Carlos… - Cell Death & …, 2018 - nature.com
Ruthenium-based compounds have gained great interest due to their potent cytotoxicity in
cancer cells; however, much of their potential applications remain unexplored. In this paper, …
cancer cells; however, much of their potential applications remain unexplored. In this paper, …